SGI-7079 T6982
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SGI-7079 is a new selective Axl inhibitor. SGI-7079 can be a dose-dependent manner inhibited growth of tumors. It is also a potential therapeutic target for EGFR inhibitor resistance.
CAS nr:
1239875-86-5
Purity:
98%
Molecular Weight:
455,53
SMILES:
CN1CCN(CC1)c1ccc(Nc2nc3c(c(C)c[nH]3)c(n2)c2cc(CC#N)ccc2)cc1F
Formula:
C26H26FN7
Pathway:
Tyrosine Kinase/Adaptors,Apoptosis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors
Target:
c-RET,c-RET,TAM Receptor,Src,Src,FLT,FLT,c-Met/HGFR
